Expanding the therapeutic frontier in atherosclerosis.
Department of Medicine, Division of Cardiovascular Medicine; and Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN (e-mail: amy.major@vanderbilt.edu).
Amy S
AS
Major
D000818:Animals; D050197:Atherosclerosis / Q000517:prevention & control*; D004351:Drug Resistance; D006801:Humans; D052456:Hypoalphalipoproteinemias / Q000188:drug therapy*; D057847:Lipid Regulating Agents / Q000627:therapeutic use*; D008075:Lipoproteins, HDL / Q000097:blood*; D058990:Molecular Targeted Therapy
D057847:Lipid Regulating Agents; D008075:Lipoproteins, HDL